Journal of Biological Chemistry
Volume 276, Issue 16, 20 April 2001, Pages 12573-12578
Journal home page for Journal of Biological Chemistry

ENZYME CATALYSIS AND REGULATION
Investigation of Invariant Serine/Threonine Residues in Mevalonate Kinase: TESTS OF THE FUNCTIONAL SIGNIFICANCE OF A PROPOSED SUBSTRATE BINDING MOTIF AND A SITE IMPLICATED IN HUMAN INHERITED DISEASE*

https://doi.org/10.1074/jbc.M011478200Get rights and content
Under a Creative Commons license
open access

Mevalonate kinase serine/threonine residues have been implicated in substrate binding and inherited metabolic disease. Alignment of >20 mevalonate kinase sequences indicates that Ser-145, Ser-146, Ser-201, and Thr-243 are the only invariant residues with alcohol side chains. These residues have been individually mutated to alanine. Structural integrity of the mutants has been demonstrated by binding studies using fluorescent and spin-labeled ATP analogs. Kinetic characterization of the mutants indicates only modest changes inKm(ATP). Km for mevalonate increases by ≈20-fold for S146A, ≈40-fold for T243A, and 100-fold for S201A. Vmax changes for S145A, S201A, and T243A are ≤3-fold. Thus, the 65-fold activity decrease associated with the inherited human T243I mutation seems attributable to the nonconservative substitution rather than any critical catalytic function. Vmax for S146A is diminished by 4000-fold. In terms of V/KMVA, this substitution produces a 105-fold effect, suggesting an active site location and catalytic role for Ser-146. The largekcat effect suggests that Ser-146 productively orients ATP during catalysis. KD(Mg-ATP)increases by almost 40-fold for S146A, indicating a specific role for Ser-146 in liganding Mg2+-ATP. Instead of mapping within a proposed C-terminal ATP binding motif, Ser-146 is situated in a centrally located motif, which characterizes the galactokinase/homoserine kinase/ mevalonate kinase/phosphomevalonate kinase protein family. These observations represent the first functional demonstration that this region is part of the active site in these related phosphotransferases.

Cited by (0)

Published, JBC Papers in Press, January 17, 2001, DOI 10.1074/jbc.M011478200

*

This work was supported in part by National Institutes of Health Grant DK-53766.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1

    The abbreviations used are:

    HMG-CoA

    3-hydroxy-3-methylglutaryl-CoA

    TNP-ATP

    2′(3′)-O-(2,4,6-trinitrophenyl)adenosine 5′-triphosphate

    ATPγSAP

    adenosine 5′-O-[S-(acetamidoproxyl)-3-thiotriphosphate]

    M2+

    divalent cation

    GHMP kinase

    galactokinase/homoserine kinase/mevalonate kinase/phosphomevalonate kinase

    PCR

    polymerase chain reaction

2

Residue numbering convention follows the sequence of the human enzyme.